Analysis of CTLA-4+49A/G gene polymorphism in cases with leprosy of Azerbaijan, Northwest Iran

被引:2
|
作者
Almasi, Shohreh [1 ]
Aliparasti, Mohammad Reza [2 ,3 ,5 ]
Naghili, Behrouz [2 ]
Yeganeh, Khalil [4 ]
Rahnama, Badrossadat [5 ]
Tavanafar, Fatemeh [5 ]
Karzar, Bita Hazhir [7 ]
Khiabani, Syamak Amini [6 ]
Naghili, Arman [2 ]
Babaloo, Zohreh [3 ,5 ]
机构
[1] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Infect & Trop Dis Res Ctr, Tabriz, Iran
[3] Tabriz Univ Med Sci, Drug Appl Res Ctr, Immunol Unit, Tabriz, Iran
[4] Tabriz Univ Med Sci, Dept Infect & Trop Dis, Fac Med, Tabriz, Iran
[5] Tabriz Univ Med Sci, Dept Immunol, Fac Med, Tabriz, Iran
[6] Tabriz Univ Med Sci, Bababaghi Hosp, Tabriz, Iran
[7] Tabriz Univ Med Sci, Med Fac, Students Res Comm, Tabriz, Iran
关键词
Leprosy; CTLA-4; Gene polymorphism; T-ARMS-PCR; Age at the disease onset; Performance status; HEPATITIS-B-VIRUS; AUTOIMMUNE THYROID-DISEASE; TYPE-1; DIABETES-MELLITUS; T-CELL-ACTIVATION; MYCOBACTERIUM-LEPRAE; CHRONIC INFECTION; CTLA4; GENE; LEPROMATOUS LEPROSY; IMMUNE-RESPONSE; EARLY-ONSET;
D O I
10.1016/j.meegid.2017.11.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Leprosy, which is developed by the obligate intracellular Mycobacterium leprae (ML); has different manifestations, associated with the host immune responses. The protective immune response against ML includes T-cell-mediated immunity. The CTLA-4 has a great impact as a negative regulator of the immune response and maintenance of peripheral tolerance. This study analyzed the relationship between CTLA-4 + 49A/G gene polymorphism and clinical manifestation of leprosy disease and susceptibility among the Azeri population living Northwest Iran. One hundred and ninety-two leprosy patients and 185 healthy controls participated in the study. CTLA-4 + 49A/G genotyping was conducted via tetra-primer amplification refractory mutation system-polymerase chain reaction (T-ARMS-PCR) analysis. The allelic and genotypic frequencies of + 49A/G gene polymorphism were similar in controls and patients. However, older ages, older age of onset and over-representation in male were observed in lepromatous leprosy patient carriers of GG genotype. The current study demonstrates that although CTLA-4 + 49A/G polymorphism was not correlated with a higher genetic risk for leprosy, the presence of a GG genotype was associated with older ages, older age of onset and over-representation in male in Iranian Azeri population.
引用
收藏
页码:121 / 127
页数:7
相关论文
共 50 条
  • [21] Meta-Analysis of CTLA-4+49 Gene Polymorphism and Susceptibility to Graves' Disease
    Huang, Fengli
    He, Qin
    Jiao, Xiaoli
    Zhang, Hong
    Chang, Qing
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2020, 30 (05): : 377 - 390
  • [22] Prevalence of CTLA-4 polymorphism A49G in Ashkenazi Jews
    Mack, R
    Chowdary, D
    Samaan, P
    Podolak, I
    Dermody, J
    GENETIC TESTING, 2001, 5 (03): : 269 - 271
  • [23] Cytotoxic T lymphocyte associated antigen-4 (CTLA-4)+49 A>G gene polymorphism in Egyptian cases with rheumatoid arthritis
    Elshazli, Rami
    Settin, Ahmad
    Salama, Afrah
    GENE, 2015, 558 (01) : 103 - 107
  • [24] CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients
    Ulker, M.
    Yazisiz, V.
    Sallakci, N.
    Avci, A. B.
    Sanlioglu, S.
    Yegin, O.
    Terzioglu, E.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2009, 36 (04) : 245 - 250
  • [25] Relationship between CTLA-4 gene+49A/G polymorphism and preeclampsia-Preliminary results
    Franchim, C. S.
    Sass, N.
    Lima, T. H.
    Lin, L. H.
    Daher, S.
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2007, 75 (01) : A17 - A17
  • [26] CTLA-4 (A49G) exon 1 gene polymorphism influences progression in multiple sclerosis
    Bilinska, M.
    Frydecka, I.
    Noga, L.
    Zoledziewska, M.
    Suwalska, K.
    Tutak, A.
    Pokryszko-Dragan, A.
    Dobosz, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 122 - 122
  • [27] EXPRESSION OF CD152 (CTLA-4) IN CHILDREN WITH AUTOIMMUNE THYROIDITIS AND+49 A/G POLYMORPHISM OF EXON 1 OF THE CTLA-4 GENE
    Kucharska, A. M.
    Gorska, E.
    Wasik, M.
    Pyrzak, B.
    Demkow, U.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2009, 60 : 77 - 80
  • [28] CTLA-4 A49G polymorphism and autoimmune blood disease: A comment
    Wiwanitkit, Viroj
    TURKISH JOURNAL OF HEMATOLOGY, 2011, 28 (03) : 247 - 247
  • [29] CTLA4+49 A/G POLYMORPHISM IN TUNISIAN BEHCET'S DISEASE PATIENTS
    Ben Dhifallah, I.
    Smiti-Khanfir, M.
    Braham-Sfaxi, A.
    Hamzaoui, A.
    Houman, M. H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : S10 - S10
  • [30] CTLA-4 A49G polymorphism and autoimmune blood diseases.
    Akturk, Faruk
    Hancer, Veysel Sabri
    Guvenc, Serkan
    Artim-esen, Bahar
    Diz-Kucukkaya, Reyhan
    BLOOD, 2006, 108 (11) : 48B - 48B